367 related articles for article (PubMed ID: 24408118)
1. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.
Elfadawy N; Flechner SM; Schold JD; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
Clin J Am Soc Nephrol; 2014 Mar; 9(3):553-61. PubMed ID: 24408118
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
Shah T; Vu D; Naraghi R; Campbell A; Min D
Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
[TBL] [Abstract][Full Text] [Related]
3. High-dose steroid therapy in BK viremia adversely affected the long-term graft function after kidney transplantation.
Kim H; Yu H; Baek CH; Han DJ; Park SK
Transpl Infect Dis; 2016 Dec; 18(6):844-849. PubMed ID: 27622599
[TBL] [Abstract][Full Text] [Related]
4. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study.
Ji J; Feng S; Jiang Y; Wang W; Zhang X
Exp Clin Transplant; 2019 Dec; 17(6):727-731. PubMed ID: 30995893
[TBL] [Abstract][Full Text] [Related]
6. BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.
Westphal SG; Lyden ER; Langewisch ED; Miles CD
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28509373
[TBL] [Abstract][Full Text] [Related]
7. BK Virus in Renal Transplant Patients Using Alemtuzumab for Induction Immunosuppression.
Korneffel K; Gehring B; Rospert D; Rees M; Ortiz J
Exp Clin Transplant; 2020 Oct; 18(5):557-563. PubMed ID: 31324134
[TBL] [Abstract][Full Text] [Related]
8. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.
Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529
[TBL] [Abstract][Full Text] [Related]
9. Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia.
Knight RJ; Graviss EA; Nguyen DT; Kuten SA; Patel SJ; Gaber L; Gaber AO
Clin Transplant; 2018 Jun; 32(6):e13265. PubMed ID: 29676018
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
12. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, Risk Factors, Treatment, and Overall Impact of BK Viremia on Kidney Transplantation.
Malik O; Saleh S; Suleiman B; Ashqar B; Maibam A; Yaseen M; Elrefaei A; Hines A; Cornea V; El-Husseini A; Mei X; Gedaly R; Castellanos AL; Waid T
Transplant Proc; 2019; 51(6):1801-1809. PubMed ID: 31399166
[TBL] [Abstract][Full Text] [Related]
14. The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation.
Elfadawy N; Flechner SM; Liu X; Schold J; Tian D; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
Transpl Int; 2013 Aug; 26(8):822-32. PubMed ID: 23763289
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of BK Virus in Renal Transplant at a Single Center: Experience With Our Ureteral Reimplantation Surgical Technique.
Martínez Moreno AI; Guimerà Garcia J; Riera Mari V; Pieras Ayala E
Exp Clin Transplant; 2020 Aug; 18(4):458-462. PubMed ID: 32490761
[TBL] [Abstract][Full Text] [Related]
16. Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft function.
Broeders EN; Hamade A; El Mountahi F; Racapé J; Hougardy JM; Le Moine A; Vereerstraeten P
Transpl Infect Dis; 2016 Dec; 18(6):872-880. PubMed ID: 27615506
[TBL] [Abstract][Full Text] [Related]
17. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.
Lee HM; Jang IA; Lee D; Kang EJ; Choi BS; Park CW; Choi YJ; Yang CW; Kim YS; Chung BH
Korean J Intern Med; 2015 Nov; 30(6):865-72. PubMed ID: 26552462
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial.
Lee BT; Gabardi S; Grafals M; Hofmann RM; Akalin E; Aljanabi A; Mandelbrot DA; Adey DB; Heher E; Fan PY; Conte S; Dyer-Ward C; Chandraker A
Clin J Am Soc Nephrol; 2014 Mar; 9(3):583-9. PubMed ID: 24482066
[TBL] [Abstract][Full Text] [Related]
19. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
Abend JR; Changala M; Sathe A; Casey F; Kistler A; Chandran S; Howard A; Wojciechowski D
Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236
[TBL] [Abstract][Full Text] [Related]
20. Treatment of BK Polyomavirus-Associated Nephropathy in Paediatric Kidney Transplant Recipients: Leflunomide Versus Cidofovir.
Kaya Aksoy G; Erkan M; Koyun M; Çomak E; Toru HS; Mutlu D; Akkaya B; Akman S
Exp Clin Transplant; 2024 Jan; 22(1):29-34. PubMed ID: 38149668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
